TSE:BLU

BELLUS Health Price Target, Predictions & Analyst Ratings

C$14.21

+1.03 (+7.81%)

(As of 07/6/2022 02:57 PM ET)

Add

Compare

Today's Range: C$12.95
▼
C$14.46
50-Day Range: C$8.40
▼
C$12.94
52-Week Range: C$3.32
▼
C$14.46

Volume: 211,201 shs
Average Volume: 117,979 shs
Market Capitalization: C$1.52 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: C$15.75

BELLUS Health (TSE:BLU) Price Target and Consensus Rating (2022)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Buy
Based on 5 Analyst Ratings

Consensus Analyst Price Target

C$15.75
10.84% Upside

High Prediction	C$18.00
Average Prediction	C$15.75
Low Prediction	C$14.00

Type	Current 7/6/21 to 7/6/22	1 Month Ago 6/6/21 to 6/6/22	3 Months Ago 4/7/21 to 4/7/22	1 Year Ago 7/6/20 to 7/6/21
Consensus Rating	Buy	Buy	Buy	Moderate Buy
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	5 Buy rating(s)	5 Buy rating(s)	5 Buy rating(s)	1 Buy rating(s)
Hold	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)	1 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	C$15.75	C$15.75	C$15.75	N/A
Predicted Upside	10.84% Upside	53.17% Upside	61.13% Upside	N/A

Get BELLUS Health Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for BLU and its competitors with MarketBeat's FREE daily newsletter.

BLU Stock Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

BLU Stock Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

BELLUS Health Stock vs. The Competition

Type	BELLUS Health	Medical Companies
Consensus Rating Score	3.00	2.72
Consensus Rating	Buy	Buy
News Sentiment Rating	Neutral News	Positive News
MarketBeat Community Rating	Outperform Votes 128 67.37% Underperform Votes 62 32.63%	Avg. Outperform Votes 167 67.07% Avg. Underperform Votes 82 32.93%

Historical BELLUS Health Price Targets and Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
5/12/2022	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Andrew Fein Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy	C$16.00	+62.60%
12/17/2021	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform	C$11.00 ➝ C$14.00	+41.84%
12/13/2021	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Justin Zelin Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	C$18.00	+68.07%
12/13/2021	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Ritu Baral Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy	C$15.00	+40.06%
8/13/2021	Bloom Burton Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Martin Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy
11/12/2020	Lifesci Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Slutsky Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform
7/7/2020	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Neutral

(Data available from 7/6/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)

BELLUS Health Price Target - Frequently Asked Questions

What is BELLUS Health's consensus rating and price target?: According to the issued ratings of 5 analysts in the last year, the consensus rating for BELLUS Health stock is Buy based on the current 5 buy ratings for BLU. The average twelve-month price prediction for BELLUS Health is C$15.75 with a high price target of C$18.00 and a low price target of C$14.00. Learn more on BLU's analyst rating history.
Do Wall Street analysts like BELLUS Health more than its competitors?: Analysts like BELLUS Health stock more than the stock of other Medical companies. The consensus rating score for BELLUS Health is 3.00 while the average consensus rating score for medical companies is 2.72. Learn more on how BLU compares to other companies.
Do MarketBeat users like BELLUS Health more than its competitors?: MarketBeat users like BELLUS Health stock more than the stock of other Medical companies. 67.37% of MarketBeat users gave BELLUS Health an outperform vote while medical companies recieve an average of 67.07% outperform votes by MarketBeat users.

Does BELLUS Health's stock price have much upside?: According to analysts, BELLUS Health's stock has a predicted upside of 53.17% based on their 12-month price targets.
What analysts cover BELLUS Health?: BELLUS Health has been rated by HC Wainwright in the past 90 days.

This page (TSE:BLU) was last updated on 7/6/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms